Skip to main content
Premium Trial:

Request an Annual Quote

Maven Biotechnologies Gets $1.9M Grant from NIAID

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Maven Biotechnologies announced it has received a $1.96 million grant from the National Institute for Allergy and Infectious Disease to support commercialization of its technology for label-free protein microarrays and cell-based assays.

The grant was awarded through the federal stimulus package initiative for Biomedical Research, Development, and Growth to Spur the Acceleration of New Technologies. Maven, based in Pasadena, Calif., will use the funds to create a product portfolio based on its Label Free Internal Reflection Ellipsometry, or LFIRE, technology.

LFIRE is a label-free, high-throughput, and high-density analysis system for microplates and slide disposables, according to the company's website, and allows for the quantitative measurement of molecular binding in real time on microarrays spotted in wells or slides.

The initial instrument based on the technology will be a desktop microplate reader, with "alpha" evaluation units expected to be finished and made available for use by academic collaborators and strategic industry partners in the first quarter of 2011, Maven said in a statement.

In addition to instruments, consumables will also be developed based on LFIRE.

Target applications for the technology include immunoassay in the research and diagnostic markets, cell-based studies, high-throughput pharmaceuticals screening, and established label-free applications in biomolecular interaction analysis.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.